Everything You Need to Know About Pacemaker cells for Step 1

Pacemaker cells are the heart’s built-in “automaticity” system—specialized cardiomyocytes that can spontaneously depolarize and set the rhythm without any external nerve input. On Step 1, they show up everywhere: conduction pathways, autonomic pharmacology, arrhythmias, electrolyte effects, and classic EKG patterns. If you can explain why phase 4 drifts upward and how vagal vs sympathetic tone shifts that slope, you’re already ahead.

---

What are pacemaker cells?

Pacemaker cells are specialized cardiac cells that spontaneously depolarize to generate rhythmic impulses. Their hallmark is automaticity due to an unstable resting membrane potential.

Where are they?

• SA node (primary pacemaker; fastest intrinsic rate)
• AV node
• His-Purkinje system (bundle of His, bundle branches, Purkinje fibers)

Intrinsic firing rates (high-yield)

Why SA node wins: fastest phase 4 depolarization → reaches threshold first → overdrives others (overdrive suppression).

First Aid cross-reference: Cardiovascular → Conduction system; Cardiac action potentials; Antiarrhythmics; Autonomic drugs.

---

The pacemaker action potential (SA/AV node)

Unlike ventricular myocytes (fast-response), SA/AV nodal cells are slow-response: they rely on calcium currents for the upstroke.

Phases you must know (SA/AV nodal AP)

Pacemaker cells have phase 4, phase 0, and phase 3 (they lack true phases 1 and 2).

Key concept: Phase 4 slope sets heart rate

• Steeper phase 4 slope → hits threshold faster → increased HR
• Flatter phase 4 slope → takes longer → decreased HR

---

Autonomic control: how HR changes mechanistically

Sympathetic (β1) stimulation

Epinephrine/norepinephrine → β1 (Gs) → ↑ cAMP

• ↑ $I_f$ (funny Na⁺ current)
• ↑ Ca²⁺ currents (T-type and L-type)
• Steeper phase 4 + threshold reached sooner → ↑ HR
• Also ↑ AV nodal conduction (positive dromotropy)

Clinical tie-in: β-blockers lower HR largely by reducing SA nodal automaticity and slowing AV nodal conduction.

Parasympathetic (M2) stimulation

Vagus → M2 (Gi) → ↓ cAMP

• ↓ $I_f$ and ↓ Ca²⁺ currents → flatter phase 4
• Opens ACh-activated K⁺ channels → hyperpolarizes membrane
• ↓ HR and ↓ AV nodal conduction

High-yield association: vagal maneuvers can terminate AVNRT by slowing AV node conduction.

First Aid cross-reference: Autonomics; Cardiovascular pharmacology (β-blockers, atropine); Arrhythmias.

---

Conduction system physiology (why AV node matters)

AV nodal delay (high yield)

The AV node delays conduction to allow ventricular filling after atrial contraction.

Mechanisms:

• Smaller diameter fibers
• Fewer gap junctions
• Slow Ca²⁺-dependent conduction

On EKG: AV nodal conduction time contributes to the PR interval.

---

Pathophysiology: what goes wrong with pacemaker cells?

1) SA node dysfunction (“sick sinus syndrome”)

Problem: SA node fails to generate appropriate rate or pauses.

• Sinus bradycardia
• Sinus pauses/arrest
• Can alternate with atrial tachyarrhythmias (“tachy-brady syndrome”)

Causes (common Step patterns):

• Fibrosis/degeneration (elderly)
• Ischemia
• Drugs: β-blockers, non-DHP CCBs, digoxin
• Post–cardiac surgery

2) AV nodal dysfunction / AV block

Pacemaker physiology is key because AV node is slow-response and Ca²⁺-dependent, so it’s sensitive to:

• Ischemia (inferior MI; RCA supplies AV node often)
• Increased vagal tone
• AV-nodal blocking drugs (β-blockers, verapamil/diltiazem, digoxin)

3) Enhanced automaticity / triggered activity

• Catecholamines (stress, stimulants) increase automaticity
• Hypokalemia can predispose to ectopy and arrhythmias
• Ischemia changes membrane potentials and conduction heterogeneity → reentry

---

Clinical presentation: how patients show up

Symptoms of bradyarrhythmias (low perfusion)

• Fatigue, exercise intolerance
• Lightheadedness, presyncope/syncope
• Chest discomfort
• Dyspnea
• Confusion in elderly

Clues pointing to nodal disease

• Symptoms worse with AV nodal blockers
• Episodic symptoms (pauses)
• Association with inferior MI (AV node involvement)

---

Diagnosis (Step-style approach)

EKG findings to recognize

Sinus bradycardia

• Normal P before every QRS, rate < 60

Sick sinus syndrome

• Sinus bradycardia, sinus pauses/arrest
• Alternating bradycardia and atrial tachyarrhythmias

AV blocks (very high yield)

Pearl:

• Mobitz I = AV nodal problem (often transient)
• Mobitz II = infranodal (His-Purkinje) problem (more likely to need pacemaker)

Other workup tools

• Holter/event monitor for intermittent pauses/blocks
• Electrolytes, TSH, medication review (bradycardia workup)
• Evaluate ischemia if clinical picture suggests MI

---

Treatment: what Step expects you to do

Acute symptomatic bradycardia (algorithm-level)

• Atropine (blocks M2 vagal effect on SA/AV nodes)
• If unstable or atropine ineffective: transcutaneous pacing → transvenous pacing
• Consider dopamine/epinephrine infusion as bridge (increases β1 stimulation)

Mechanism connection: atropine increases HR by increasing cAMP indirectly (removing Gi signaling) → steeper phase 4.

Chronic management

• Permanent pacemaker for:
  • Symptomatic sick sinus syndrome
  • Mobitz II
  • Third-degree AV block
  • Some symptomatic bradycardias not reversible

Treat the cause when reversible:

• Stop AV nodal blocking drugs if appropriate
• Correct electrolytes
• Treat ischemia/infection (e.g., Lyme can cause AV block)

---

Pacemaker cells + pharmacology: high-yield drug hooks

Antiarrhythmics that target nodal tissue

Class II (β-blockers) and Class IV (non-DHP CCBs: verapamil, diltiazem):

• Slow SA rate (↓ phase 4 slope)
• Slow AV nodal conduction (↑ PR interval)
• Used for rate control in atrial fibrillation/flutter
• Can cause bradycardia/AV block

Adenosine (often tested):

• Activates Gi → ↓ cAMP in AV node; increases K⁺ efflux
• Very short half-life
• Used for AVNRT/PSVT
• Side effects: flushing, chest tightness, dyspnea/bronchospasm (caution in asthma)

Digoxin:

• Increases vagal tone → slows AV nodal conduction
• Can precipitate AV block/bradycardia and various arrhythmias (toxicity)

First Aid cross-reference: Antiarrhythmic drugs; Adenosine; Digoxin; β-blockers; Calcium channel blockers.

---

HY associations & classic testable connections

Electrolytes

• Hyperkalemia: can depress conduction and lead to bradyarrhythmias; classic EKG progression (peaked T → widened QRS → sine wave).
• Hypokalemia: predisposes to ectopy and tachyarrhythmias; think U waves.

MI territory links

• Inferior MI (RCA) → AV nodal ischemia → bradycardia, Mobitz I, 3rd-degree sometimes (often nodal escape with narrow QRS).
• Anterior MI (LAD) → His-Purkinje damage → Mobitz II, wide QRS escape (worse prognosis).

Reentry circuits involving AV node

• AV node is a critical limb in AVNRT and AVRT (WPW uses an accessory pathway).
• Vagal maneuvers/adenosine can terminate AVNRT (AV nodal-dependent).

---

Rapid Step 1 recap: memorize this mini-table

---

Exam-day pitfalls (don’t fall for these)

• Pacemaker phase 0 is Ca²⁺, not Na⁺ → that’s why non-DHP CCBs slow AV node.
• Mobitz I vs II: progressive PR then drop (I) vs constant PR with dropped beats (II).
• Atropine works at the AV node (vagolytic). If block is infranodal (Mobitz II), atropine may be ineffective—pacing is often needed.
• SA node sets rhythm because it’s fastest, not because it’s “strongest.”